相关实验视频
Updated: Jun 21, 2025

08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
111.5K
通过增强细胞增殖,迁移和入侵,CALU促进肺腺癌的进展
Yan Li1, Shengnan Sun2, Hui Zhang3
1Department of Pulmonary and Critical Care Medicine, The Second Hospital of Shandong University, Jinan, Shandong, 250033, China.
Respiratory research
|July 5, 2024
概括
氨酸促进肺腺癌细胞的生长和迁移. 它的击倒抑制MYC和KRAS通路,同时激活干扰素,炎症和p53通路,这表明它是一种新的抗癌机制.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 肺癌是全球癌症死亡的主要原因之一.
- 素,一个分子伴侣,涉及瘤发育,但其在肺腺癌中的作用尚不清楚.
- 这项研究调查了calumenin在肺腺癌中的影响和调节机制.
研究的目的:
- 阐明胺在肺腺癌扩散和迁移中的作用.
- 探索卡卢明因在肺腺癌中的作用背后的分子机制.
- 通过了解素的调节途径来确定潜在的治疗点.
主要方法:
- 细胞增殖和迁移试验 (5-乙基-2'-脱氧化,殖民地形成,Transwell,伤口愈合).
- 转录基因分析包括基因本体学,KEGG,GSEA和IPA在素敲击A549细胞上.
- 在 calumenin-knockdown 和正常 A549 细胞之间对基因表达特征的比较.
主要成果:
- 氨酸在肺腺癌中表达很高,与预后不佳相关.
- 氨酸倒置抑制肺腺癌细胞的增殖和迁移.
- Knockdown 抑制了 MYC 和 KRAS 信号,同时激活了干扰素,炎症和 p53 途径.
结论:
- 氨酸 Knockdown 通过抑制 MYC 和 KRAS 信号传递,表现出抗癌效应.
- 干扰素,炎症和p53通路的激活有助于calumenin knockdown的抗癌机制.
- 这些发现凸显了calumenin作为肺腺癌的潜在治疗点.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K

